Sublicensing Terms. (a)Xencor will have the right to sublicense any of its rights under Section 9.2.2.1 to any of its Affiliates or to any Third Party without the prior consent of Novartis, subject to the requirements of this Section 9.2.2.2.
Appears in 1 contract
Sublicensing Terms. (a)Xencor a)Novartis will have the right to sublicense any of its rights under Section 9.2.2.1 9.3.1.1 to any of its Affiliates or to any Third Party (which sublicensed rights may be further sublicensable through multiple tiers) without the prior consent of NovartisXencor, subject to the requirements of this Section 9.2.2.2.9.3.1.2. -85- ***Confidential Treatment Requested
Appears in 1 contract
Sublicensing Terms. (a)Xencor will have the right to sublicense any of its rights under Section 9.2.2.1 9.1.2.1 to any of its Affiliates or to any Third Party (which sublicensed rights may be further sublicensable through multiple tiers) without the prior consent of Novartis, subject to the requirements of this Section 9.2.2.29.1.2.2.
Appears in 1 contract
Sublicensing Terms. (a)Xencor a)Novartis will have the right to sublicense any of its rights under Section 9.2.2.1 9.1.1.1 to any of its Affiliates or to any Third Party (which sublicensed rights may be further sublicensable through multiple tiers) without the prior consent of NovartisXencor, subject to the requirements of this Section 9.2.2.29.1.1.2.
Appears in 1 contract
Sublicensing Terms. (a)Xencor a)Novartis will have the right to sublicense any of its rights under Section 9.2.2.1 9.2.1.1 to any of its Affiliates or to any Third Party (which sublicensed ***Confidential Treatment Requested rights may be further sublicensable through multiple tiers) without the prior consent of NovartisXencor, subject to the requirements of this Section 9.2.2.29.2.1.2.
Appears in 1 contract